Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -92,771 | -65,302 | N/A | N/A |
| Depreciation Amortization | 36,755 | 11,910 | N/A | N/A |
| Income taxes - deferred | -11,152 | 1,176 | N/A | N/A |
| Accounts receivable | -6,602 | -12,782 | N/A | N/A |
| Other Working Capital | 5,228 | 21,882 | N/A | N/A |
| Other Operating Activity | 60,694 | 17,927 | 0 | 0 |
| Operating Cash Flow | $-7,848 | $-25,189 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -87,154 | -91,673 | N/A | N/A |
| Net Acquisitions | -14,768 | -28,608 | N/A | N/A |
| Purchase Sale Intangibles | -2,105 | -4,453 | N/A | N/A |
| Other Investing Activity | 37,173 | 12,685 | 0 | 0 |
| Investing Cash Flow | $-64,749 | $-107,596 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 11,754 | N/A | N/A | N/A |
| Debt Issued | 186,000 | 55,476 | N/A | N/A |
| Debt Repayment | -17,945 | -3,196 | N/A | N/A |
| Common Stock Issued | 6,200 | 3,177 | N/A | N/A |
| Other Financing Activity | -24,523 | -6,548 | 0 | 0 |
| Financing Cash Flow | $161,486 | $48,909 | $N/A | $N/A |
| Exchange Rate Effect | -1,124 | N/A | N/A | N/A |
| Beginning Cash Position | 53,009 | 138,028 | N/A | N/A |
| End Cash Position | 140,774 | 54,152 | N/A | N/A |
| Net Cash Flow | $87,765 | $-83,876 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -7,848 | -25,189 | N/A | N/A |
| Capital Expenditure | -87,154 | -91,673 | N/A | N/A |
| Free Cash Flow | -95,002 | -116,862 | 0 | 0 |